指标,指标类型,分层,治疗组例数,治疗组变化均值,治疗组变化SD,对照组例数,对照组变化均值,对照组变化SD,组间差异,t检验P值,Mann-Whitney P值,Cohen's d,统计学差异,临床意义
ALT,主要,全人群,93,-0.989247311827957,8.665893445566427,78,0.41025641025641024,13.41102076113067,-1.3995037220843671,0.4291605161030466,0.5346164415338901,-0.12395351108809116,否,治疗组更优
AST,主要,全人群,93,0.946236559139785,8.465230153523716,78,0.5769230769230769,9.765456254785837,0.3693134822167081,0.7939864750493947,0.4381171631372943,0.040412934355209824,否,对照组更优或无差异
GGT,次要,全人群,93,2.236559139784946,21.07409178478469,78,1.3205128205128205,12.110415812934384,0.9160463192721255,0.7230300908684751,0.922086900726811,0.053299080605485646,否,对照组更优或无差异
ALP,次要,全人群,94,-1.5557823663343018,16.96770227718887,78,-2.58974358974359,13.094497602652323,1.033961223409288,0.6527236970814169,0.30916512759055514,0.06822420879236704,否,对照组更优或无差异
白蛋白,次要,全人群,95,0.2736842105263158,2.459121557667766,78,0.3307692307692308,3.641867213833695,-0.05708502024291501,0.9061816465151779,0.36676651773534164,-0.01837133310160322,否,对照组更优或无差异
胆红素,次要,全人群,93,-0.49999999999999967,7.957167947148687,78,2.037179487179487,5.750056103043273,-2.5371794871794866,0.016871468211401463,0.0375759336481182,-0.36548829991172843,是,治疗组更优
